Philip Taylor | IR |
Drew Spaventa | Founder & CEO |
Dalen Meeter | Head, Finance |
Eli Glezer | Founder and Chief Scientific Officer |
Dan Brennan | Cowen |
Matt Sykes | Goldman Sachs |
Michael Ryskin | Bank of America |
Good day, ladies and gentlemen, and welcome to the Singular Genomics Systems, Incorporated Second Quarter 2022 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be opened for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Philip Taylor with the Gilmartin Group. Sir, the floor is yours.
Thank you, operator.